Prolia works similarly to alendronate by slowing down the cells that break down bone, called osteoclasts. Unlike alendronate and similar drugs, Prolia stops working as soon as you stop taking it, so ...
Unlike alendronate and similar drugs, Prolia stops working as soon as you stop taking it, so people who are on it need to take it continuously.
Emma Operacz was feeling under the weather, and she initially believed she had a UTI. But a series of doctors and medical ...
Father-of-three Mark Jaquez needed to go to the bathroom more than a dozen times day, suddenly interrupting what he was doing ...
A newly discovered cancer trick that weakens immunotherapy may be stopped by everyday statins.
The study explores the neoadjuvant approach: administering the immunotherapy drug Keytruda (pembrolizumab) before a surgeon ever picks up a scalpel. Researchers observed dramatic tumor shrinkage and, ...
Radiation therapy works by using high-energy X-rays to kill cancer cells. MSK offers precise radiation therapy that kills throat cancer cells with fewer side effects from radiatio ...
Scientists have identified a crucial molecular switch that decides whether pancreatic cancer cells resist chemotherapy or respond to it. The key player, a gene called GATA6, keeps tumours in a more ...
Scientists at Duke-NUS Medical School have identified a molecular “switch” that determines whether pancreatic cancer cells resist chemotherapy or respond to it—a finding that could help convert some ...
Scientists at Duke-NUS Medical School have identified a molecular "switch" that determines whether pancreatic cancer cells resist chemotherapy or respond to it—a finding that could help convert some ...
Structural nanomedicine — what helped give us the COVID vaccine — may now be the key to a potent blood cancer treatment that’s had remarkable early results.
Hundreds of dancers and volunteers filled Penn State's Bryce Jordan Center, standing for 46 straight hours to raise money for pediatric cancer research and to support children and families affected by ...